Downloadable Slidesets

Share

Program Content

Activities

  • PARPi Combos in Prostate Cancer
    PARP Inhibitor Combinations in Prostate Cancer: Current Clinical Evidence and Key Ongoing Trials
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 14, 2021

    Expires: June 13, 2022

  • PARPi monotherapy
    Single-Agent PARP Inhibitors in Prostate Cancer
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 15, 2021

    Expires: June 14, 2022

  • Rationale for PARPi Combos
    Understanding the Interdependencies of Targeted Pathways: Rationale for PARP Inhibitor Combinations
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 15, 2021

    Expires: June 14, 2022

  • <i>EP</i>: Prostate Ca PARPi Combos
    ExpressPoints
    PARP Inhibitor Combinations in Prostate Cancer: Expanding Treatment Options to Broader Patient Populations
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 23, 2021

    Expires: June 22, 2022

Faculty

cover img faculity

Charles Ryan, MD

Associate Clinical Professor
Department of Medicine Hematology/Oncology
University of California, San Francisco
San Francisco, California

cover img faculity

Wassim Abida, MD, PhD

Director of Translational Research, Prostate Cancer
Associate Member
Genitourinary Oncology Service
Memorial Sloan Kettering Cancer Center
Associate Professor of Medicine
Weill Cornell Medical College
New York, New York

cover img faculity

Joaquin Mateo, MD, PhD

Medical Oncology Department
Vall d’Hebron University Hospital
Group Leader
Vall d’Hebron Institute of Oncology
Barcelona, Spain

Provided by

ProCE Banner

Supporters

AstraZeneca

Merck Sharp & Dohme Corp.

Pfizer, Inc.